טוען...
Enhancing poxvirus vectors vaccine immunogenicity
Attenuated recombinant poxvirus vectors expressing heterologous antigens from pathogens are currently at various stages in clinical trials with the aim to establish their efficacy. This is because these vectors have shown excellent safety profiles, significant immunogenicity against foreign expresse...
שמור ב:
הוצא לאור ב: | Hum Vaccin Immunother |
---|---|
Main Authors: | , |
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
Taylor & Francis
2014
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4896794/ https://ncbi.nlm.nih.gov/pubmed/25424927 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.28974 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|